More than 1.4 billion doses of vaccines have been administered in China, and the country has provided over 500 million doses of vaccines overseas to assist in the global fight against the pandemic.
Russia actively fosters localization of its vaccine production abroad, which is based on technology transfer, while agreements were inked with several foreign companies.
Sputnik Light demonstrated 79.4% efficacy according to analyzed data taken from 28 days after the injection was administered. In February 2021, Kazakhstan approved the two-dose Sputnik V vaccine.
The WTO Secretariat has published an indicative list compiling information on the critical inputs for the manufacturing, distributing and administering of COVID-19 vaccines.
The first batch of Sputnik vaccine is expected to be produced at SII’s facilities in September. The parties intend to produce over 300 million doses of the vaccine in India per year.
Aikening™ is a new fusion inhibitor. It is the first and only long-acting injectable (as IV infusion QW) available as a dual therapy for treatment-experienced patients with HIV-1 replication.